EquitAI LogoEquitAI
$827.72
-1.87%
REGN

REGN

Regeneron Pharmaceuticals, Inc.

Healthcare
Loading Chart...
FIT ANALYSIS
Required for personalization
STOCK DNA
Valuation
5/10
Quality
10/10
Growth
5/10
Strength
5/10
Dividend
3/10
Price Trend
Upwards
Momentum
Stretched
Balance Sheet
High Leverage
Earnings
Growth
Dividend Yield
0.45%
Market Cap
$85.22B
TALK TO YOUR STOCK
EQUITAI ASSISTANT

Regeneron Pharmaceuticals is a leading biotechnology company that invents, develops, and commercializes medicines for serious medical conditions. Its core products focus on highly effective treatments for eye diseases, allergic and inflammatory conditions, cancer, and cardiovascular issues. I have synthesized my analysis of its core fundamentals, live market action, and peer metrics to provide a comprehensive thesis. What specific areas can I detail for you?

AI can make mistakes. Verify important information.
Talk to Your Stockopen live chat
Pro EquitAI Research
Retrieving premium status...